Clinical Trial Update: Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine

View source ↗

Summary

This clinical trial update indicates recruitment for a study evaluating the long-term immunogenicity of a booster dose of the MVA-BN vaccine for monkeypox.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• MVA-BN vaccine (Modified Vaccinia Ankara-Bavarian Nordic vaccine (MVA-BN))

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Monkeypox | Status: RECRUITING